Can a Strong June Salvage H World Group’s Second Quarter Malaise?

Chinese hotelier is enjoying rising room rates and occupancies at its over 8,000 hotels, but that’s unlikely to offset a disastrous April and May Key Takeaways H World Group’s average occupancy and revpar are recovering after steep declines in April and May due to pandemic restrictions, but still lag 2019 levels Investors are watching whether the company’s loss will narrow in the second quarter on the back of improving hotel performance metrics By Andrew Curran Ahead of soon-to-be-released second-quarter results, hotelier H World Group Ltd. (HTHT.US; 1179.HK) is reporting some…

Read More »

FAST NEWS: Antengene Corporation Announces First Ever Revenue of $7.8 Million

The latest: Antengene Corp. Ltd. (6996.HK), a biopharmaceutical company, announced Thursday it expects revenue for the six months ended June 30 this year to range from 53 million yuan ($7.8 million) to 55 million yuan, compared with zero revenue recorded in the same period last year. Looking up: The increase in revenue was mainly attributable to the launch of the first-in-class XPO1 inhibitor, Xpovio, in Mainland China on May 13 this year. As the drug has already generated over 53 million yuan in revenue in just over a month, its…

Read More »

3D Medicines Bleeds Red Ink As It Struggles to Swim in ‘Red Ocean’

The loss-making innovative oncology drug company with just one approved product on the market is making a third tilt for a listing on the Hong Kong Stock Exchange Key Takeaways: 3D Medicines competes for a share in an already hotly contested and very small market, potentially dimming its appeal to investors The company lost 1.46 billion yuan last year and another 290 million yuan in the first five months of this year, leaving it with only 660 million yuan in cash and cash equivalents and desperate for funds By Ellie…

Read More »